[Skip to Content]
Access to paid content on this site is currently suspended due to excessive activity being detected from your IP address 54.159.197.114. Please contact the publisher to request reinstatement.
[Skip to Content Landing]
Editorial
February 17, 2015

Corticosteroids for Severe Community-Acquired PneumoniaNot for Everyone

Author Affiliations
  • 1Northwestern University Feinberg School of Medicine, Chicago, Illinois
JAMA. 2015;313(7):673-674. doi:10.1001/jama.2015.115

Corticosteroids are the physician’s immunomodulatory agent of choice. These agents are inexpensive and ubiquitously available, have a well-known adverse effect profile, do not require monitoring of drug levels, and, probably most important, mimic the body’s own response to stress. Accordingly, corticosteroids have been used for a wide variety of medical illnesses. Use of corticosteroids for acute illness has always been controversial, no more so than for treating the triad of community-acquired pneumonia,1 septic shock,2,3 and acute respiratory distress syndrome.4,5

First Page Preview View Large
First page PDF preview
First page PDF preview
×